PropertyValue
?:abstract
  • To identify key gene expression pathways altered with infection of the novel coronavirus SARS-CoV-2, we performed the largest comparative genomic and transcriptomic analysis to date. We compared the novel pandemic coronavirus SARS-CoV-2 with SARS-CoV and MERS-CoV, as well as influenza A strains H1N1, H3N2 and H5N1. Phylogenetic analysis confirms that SARS-CoV-2 is closely related to SARS-CoV at the level of the viral genome. RNAseq analyses demonstrate that human lung epithelial cell responses to SARS-CoV-2 infection are distinct. Extensive Gene Expression Omnibus literature screening and drug predictive analyses show that SARS-CoV-2 infection response pathways are closely related to those of SARS-CoV and respiratory syncytial virus infections. We validated SARS-CoV-2 infection response genes as disease-associated using Kaplan–Meier survival estimates in lung disease patient data. We also analysed COVID-19 patient peripheral blood samples, which identified signalling pathway concordance between the primary lung cell and blood cell infection responses.
is ?:annotates of
?:creator
?:doi
  • 10.1093/bib/bbaa376
?:doi
?:journal
  • Brief_Bioinform
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/17761d2312188477df833b45ce68dc8ed825431a.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7799202.xml.json
?:pmcid
?:pmid
?:pmid
  • 33333559.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Gene expression profiling of SARS-CoV-2 infections reveal distinct primary lung cell and systemic immune infection responses that identify pathways relevant in COVID-19 disease
?:type
?:year
  • 2020-12-18

Metadata

Anon_0  
expand all